Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Slowing of brain atrophy with Teriflunomide

Slowing of brain atrophy with Teriflunomide

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite Multiple sclerosis.

APSC Consensus Recommendations on Dyslipidemia

APSC Consensus Recommendations on Dyslipidemia

APSC Consensus Recommendations on Dyslipidemia

APSC Consensus Recommendations on Dyslipidemia

APSC Consensus Recommendations on Dyslipidemia

APSC Consensus Recommendations on Dyslipidemia

APSC Consensus Recommendations on Dyslipidemia

APSC Consensus Recommendations on Dyslipidemia

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Independent Risk Factors for Venous Thromboembolism

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.